FDA approves first absorbable stent for CAD
On July 5, the Food and Drug Administration (FDA) approved the first fully absorbable stent to treat coronary artery disease (CAD): Absorb GT1 Bioresorbable…
Web Exclusives
Switching to pill organizer can put older people at risk for adverse effects
Older people who switch to using pill organizers could experience adverse effects and even hospitalization, according to a study in Health Technology Assessment. Read…
Medical marijuana lowers prescription drug use
Legalized medical marijuana saved Medicare $165.2 million in 2013 by lowering prescription drug use, according to a study in Health Affairs. Read more and access…
Secondary postpartum hemorrhage: Risk factors, assessment, and intervention
Jayne Kennedy, a 35-year-old, gravida 2, para 2, is admitted to the emergency department with heavy vaginal bleeding. Two weeks earlier, she’d delivered an…
Obesity may affect quality of care in nursing home
A study in the Journal of the American Geriatrics Society indicates that nursing homes that admit more morbidly obese residents are more likely to…
Restrictions on CRNA practice do not improve patient safety
A study in Medical Care reports that scope of practice restrictions and physician requirements for certified registered nurse anesthetists (CRNAs) have no effect on…
FDA approvals
On June 1, the Food and Drug Administration (FDA) approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate injection, a…
Improving outcomes for patients with multiple myeloma
Over the last decade, progress in multiple myeloma (MM) treatment has extended survival with good quality of life. We’ve increased our understanding of how…
2016 American Nurse Today’s Spirit of Caring
We are pleased to announce that COLLEEN BIDWELL from Los Alamitos Medical Center, who was nominated by Judy Chabot, has received the most votes this year…
Pregabalin may increase risk of birth defects
Pregabalin may increase the risk of major birth defects according to a study in Neurology. Read more and read the study abstract.
FDA approves new treatment for bladder cancer
On May 18, the U.S. the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) to treat urothelial carcinoma. Read more
New TB test safe, effective
A new skin test for tuberculosis (TB), C-Tb, is safe, easy to administer, and accurate, according to results from two Phase III clinical trials…
FDA approves first absorbable stent for CAD
On July 5, the Food and Drug Administration (FDA) approved the first fully absorbable stent to treat coronary artery disease (CAD): Absorb…
Switching to pill organizer can put older people at risk for adverse effects
Older people who switch to using pill organizers could experience adverse effects and even hospitalization, according to a study in Health Technology…
Medical marijuana lowers prescription drug use
Legalized medical marijuana saved Medicare $165.2 million in 2013 by lowering prescription drug use, according to a study in Health Affairs. Read…
Secondary postpartum hemorrhage: Risk factors, assessment, and intervention
Jayne Kennedy, a 35-year-old, gravida 2, para 2, is admitted to the emergency department with heavy vaginal bleeding. Two weeks earlier, she’d…
Obesity may affect quality of care in nursing home
A study in the Journal of the American Geriatrics Society indicates that nursing homes that admit more morbidly obese residents are more…
Restrictions on CRNA practice do not improve patient safety
A study in Medical Care reports that scope of practice restrictions and physician requirements for certified registered nurse anesthetists (CRNAs) have no…
FDA approvals
On June 1, the Food and Drug Administration (FDA) approved Netspot, the first kit for the preparation of gallium Ga 68 dotatate…
Improving outcomes for patients with multiple myeloma
Over the last decade, progress in multiple myeloma (MM) treatment has extended survival with good quality of life. We’ve increased our understanding…
2016 American Nurse Today’s Spirit of Caring
We are pleased to announce that COLLEEN BIDWELL from Los Alamitos Medical Center, who was nominated by Judy Chabot, has received the most votes…
Pregabalin may increase risk of birth defects
Pregabalin may increase the risk of major birth defects according to a study in Neurology. Read more and read the study abstract.
FDA approves new treatment for bladder cancer
On May 18, the U.S. the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) to treat urothelial carcinoma. Read more
New TB test safe, effective
A new skin test for tuberculosis (TB), C-Tb, is safe, easy to administer, and accurate, according to results from two Phase III…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.